Literature DB >> 10964771

Down-regulation of Bgp1(a) viral receptor by interferon-gamma is related to the antiviral state and resistance to mouse hepatitis virus 3 infection.

R C Vassão1, M T de Franco, D Hartz, M Modolell, A E Sippel, C A Pereira.   

Abstract

Together with the evidence that the reduced virus growth and the antiviral state induced by interferon (IFN)-gamma, occurring only in macrophages from resistant animals, correlated with the decrease of MHV3 binding to macrophage membrane proteins, we show here the expression of cellular and viral genes in resistant (A/J) and susceptible (BALB/c) mouse macrophages after IFN-gamma activation/infection. The expression of interferon response gene 47 and interferon regulatory factor 1 genes takes place after IFN-gamma activation in both macrophages, indicating their activation. The expression of the biliary glycoprotein 1(a) (Bgp1(a), the main virus receptor) decreased only in IFN-gamma-activated A/J mouse macrophages, in contrast to the expression of the Bgp2 (alternative receptor), which was not influenced by IFN-gamma activation. The synthesis of both viral mRNA and virus particles was delayed only in IFN-gamma-activated A/J mouse macrophages compared with susceptible BALB/c macrophages. Besides the evidence that IFN-gamma may modulate the expression of the Bgp1(a) isoform of carcinoembryonic antigen family, these data show that IFN-gamma, which induces resistance against MHV3 infection, may be involved in the down-regulation of the main viral receptor expression, a key step forward in our understanding of the molecular basis of resistance against virus infection. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10964771     DOI: 10.1006/viro.2000.0463

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  7 in total

1.  Expression of the mouse hepatitis virus receptor by central nervous system microglia.

Authors:  Chandran Ramakrishna; Cornelia C Bergmann; Kathryn V Holmes; Stephen A Stohlman
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

2.  Mouse hepatitis virus 3 binding to macrophages correlates with resistance to experimental infection.

Authors:  C A Pereira; C Moreira; M H Tsuhako; M T de Franco
Journal:  Scand J Immunol       Date:  2005-07       Impact factor: 3.487

3.  Arginine metabolism during macrophage autocrine activation and infection with mouse hepatitis virus 3.

Authors:  Cristiani Moreira; Maria H Tsuhako; Milene Tino de Franco; Manuel Modolell; Carlos A Pereira
Journal:  Immunobiology       Date:  2004       Impact factor: 3.144

4.  Association between nitric oxide synthesis and vaccination-acquired resistance to murine hepatitis virus by spf mice.

Authors:  Maria H Tsuhako; Ohara Augusto; Edlaine Linares; Maria L Z Dagli; Carlos A Pereira
Journal:  Free Radic Biol Med       Date:  2006-08-16       Impact factor: 7.376

5.  Interferon-beta 1a and SARS coronavirus replication.

Authors:  Lisa E Hensley; Lisa E Fritz; Peter B Jahrling; Christopher L Karp; John W Huggins; Thomas W Geisbert
Journal:  Emerg Infect Dis       Date:  2004-02       Impact factor: 6.883

6.  A synergistic interferon-gamma production is induced by mouse hepatitis virus in interleukin-12 (IL-12)/IL-18-activated natural killer cells and modulated by carcinoembryonic antigen-related cell adhesion molecules (CEACAM) 1a receptor.

Authors:  Alexandre Jacques; Christian Bleau; Claire Turbide; Nicole Beauchemin; Lucie Lamontagne
Journal:  Immunology       Date:  2008-12-18       Impact factor: 7.397

7.  The NLRP3 Inflammasome and IL-1β Accelerate Immunologically Mediated Pathology in Experimental Viral Fulminant Hepatitis.

Authors:  Sheng Guo; Chengying Yang; Bo Diao; Xiaoyong Huang; Meihua Jin; Lili Chen; Weiming Yan; Qin Ning; Lixin Zheng; Yuzhang Wu; Yongwen Chen
Journal:  PLoS Pathog       Date:  2015-09-14       Impact factor: 6.823

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.